Dirix Prové Oncologen
0811.474.086 · rovalta.com · 25/09/2026
NORMAL SITUATION
Dirix Prové Oncologen
Company — Normal situation.
Financial year 2022 · Closed on 30/09/2022
Net result273,1 k €-43,0 %over 1 year
Gross margin398,5 k €-41,6 %over 1 year
Equity2,5 M €+12,2 %over 1 year
Overview
Identity
Source · BCE/KBODirix Prové Oncologen is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0811.474.086
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2022
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 398,5 k € | -41.6% | 682,2 k € | +13.8% | 599,5 k € | -24.2% | 790,6 k € | +15.5% | 684,6 k € |
| EBITDA | 396,4 k € | -41.7% | 680 k € | +13.7% | 598,1 k € | -24.1% | 788,1 k € | +15.6% | 681,8 k € |
| Operating result | 372,2 k € | -43.7% | 661 k € | +13.7% | 581,6 k € | -23.4% | 759 k € | +48.7% | 510,5 k € |
| Net result | 273,1 k € | -43.0% | 478,9 k € | +25.2% | 382,5 k € | -21.5% | 487,3 k € | +58.8% | 306,9 k € |
| Balance sheet | |||||||||
| Equity | 2,5 M € | +12.2% | 2,2 M € | +3.1% | 2,2 M € | +21.5% | 1,8 M € | +37.7% | 1,3 M € |
| Total assets | 2,6 M € | +2.3% | 2,6 M € | +0.3% | 2,5 M € | +10.1% | 2,3 M € | +28.6% | 1,8 M € |
| Cash | 162,8 k € | -74.2% | 630,6 k € | -13.8% | 731,6 k € | -55.4% | 1,6 M € | +30.7% | 1,3 M € |
| Debts | 110,7 k € | -65.9% | 324,6 k € | -15.8% | 385,3 k € | -26.6% | 525,3 k € | +3.7% | 506,8 k € |
Board of directors
Source · NBB, accounts to 30/09/20222 active · 3 ended
Active mandates
Anna Maria Prové
ActiveLuc Mathieu Dirix
ActiveEnded mandates
Anna Maria Prove
EndedLuc Dirix
EndedLuc Mathieu Dirix
EndedFinancials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 | 01/10/2017 | 01/10/2016 |
| Closing of the financial year | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 | 30/09/2018 | 30/09/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/05/2023 | 28/04/2022 | 30/04/2021 | 30/04/2020 | 02/05/2019 | 15/05/2018 |
| General meeting | 17/03/2023 | 18/03/2022 | 02/04/2021 | 20/03/2020 | 15/03/2019 | 16/03/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2022 | 17/03/2023 | 03/05/2023 | Dutch | |
| Abridged model | 30/09/2021 | 18/03/2022 | 28/04/2022 | Dutch | |
| Abridged model | 30/09/2020 | 02/04/2021 | 30/04/2021 | Dutch | |
| Abridged model | 30/09/2019 | 20/03/2020 | 30/04/2020 | Dutch | |
| Abridged model | 30/09/2018 | 15/03/2019 | 02/05/2019 | Dutch | |
| Abridged model | 30/09/2017 | 16/03/2018 | 15/05/2018 | Dutch | |
| Abridged model | 30/09/2016 | 17/03/2017 | 28/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 18/03/2016 | 30/03/2016 | Dutch | |
| Abridged model | 30/09/2014 | 20/03/2015 | 30/04/2015 | Dutch | |
| Abridged model | 30/09/2013 | 21/03/2014 | 30/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 15/03/2013 | 30/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 16/03/2012 | 27/04/2012 | Dutch | |
| Abridged model | 30/09/2010 | 18/03/2011 | 28/04/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20222 active · 3 ended
Active mandates
Anna Maria Prové
ActiveLuc Mathieu Dirix
ActiveEnded mandates
Anna Maria Prove
EndedLuc Dirix
EndedLuc Mathieu Dirix
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution12/03/2024RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Capital / shares26/11/2018KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates20/10/2014KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022273,1 k €↓
- 2021Annual accounts 2021478,9 k €↑
- 2020Annual accounts 2020382,5 k €↓
- 2019Annual accounts 2019487,3 k €↑
- 2018Annual accounts 2018306,9 k €↑
- 2017Annual accounts 2017269,4 k €↑
- 2016Annual accounts 2016253,9 k €↑
- 2015Annual accounts 2015152,2 k €↑
- 2014Annual accounts 2014125,6 k €↓
- 2013Annual accounts 2013163,6 k €↓
- 2012Annual accounts 2012213,1 k €↑
- 2011Annual accounts 2011170,6 k €↑
- 2010Annual accounts 2010-48,2 k €